1. Research Progress of the Brain-Gut Axis as a Therapeutic Target for Central Nervous System Diseases
   刚 安, 2023, Advances in Clinical Medicine CrossRef
2. Gut microbiota’s role in glioblastoma risk, with a focus on the mediating role of metabolites
   Junqing Yan et al, 2024, Frontiers in Neurology CrossRef
3. Current understanding of the human microbiome in glioma
   Jianhao Liang et al, 2022, Frontiers in Oncology CrossRef
4. Aryl Hydrocarbon Receptors: Evidence of Therapeutic Targets in Chronic Inflammatory Skin Diseases
   Han-Bi Kim et al, 2022, Biomedicines CrossRef
5. The tryptophan metabolism, kynurenine pathway and oxidative stress – implications for glioma pathobiology
   Marta Obara-Michlewska, 2022, Neurochemistry International CrossRef
6. Changes in the Number of p23-Positive Fibroblasts in Human Dermis with Aging
   A. G. Gunin et al, 2022, Advances in Gerontology CrossRef
7. Aryl Hydrocarbon Receptor in Oxidative Stress as a Double Agent and Its Biological and Therapeutic Significance
   Alevtina Y. Grishanova et al, 2022, International Journal of Molecular Sciences CrossRef
8. Kynurenine attenuates mitochondrial depolarization and neuronal cell death induced by rotenone exposure independently of AhR-mediated parkin induction in SH-SY5Y differentiated cells
   Rosario García-Aguilar et al, 2023, NeuroToxicology CrossRef
9. Aryl Hydrocarbon Receptor (AhR)-Mediated Signaling in iPSC-Derived Human Motor Neurons
   Saima Jalil Imran et al, 2022, Pharmaceuticals CrossRef
10. Kynurenic Acid/AhR Signaling at the Junction of Inflammation and Cardiovascular Diseases
    Alevtina Y. Grishanova et al, 2024, International Journal of Molecular Sciences CrossRef